(Q57707731)

2

0 references

Yoko Oshima

3

0 references

Takaki Hiwasa

4

0 references

Masatoshi Tagawa

5

0 references

Kazuyuki Matsushita

6

0 references

Fumio Nomura

Esophagus : official journal of the Japan Esophageal Society

7

0 references

publication date

8 June 2012

0 references

published in

0 references

volume

9

0 references

issue

3

0 references

page(s)

131-140

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s10388-012-0332-x

0 references

cites work

Treatment response and prognosis of patients after recurrence of esophageal cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Have surgical outcomes of pathologic T4 esophageal squamous cell carcinoma really improved? Analysis of 268 cases during 45 years of experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Carcinoembryonic antigen measurements in the management of esophageal cancer: an indicator of subclinical recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Value of serial carcinoembryonic antigen levels in patients with resectable adenocarcinoma of the esophagus and stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Clinical significance of serum vascular endothelial growth factor in esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Prognostic significance of serum thymidine phosphorylase concentration in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Human neoplasms elicit multiple specific immune responses in the autologous host

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Expression of angiogenic factors predicts response to chemoradiotherapy and prognosis of oesophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

The prognostic significance of microvessel density and thymidine phosphorylase expression in squamous cell carcinoma of the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Basic fibroblast growth factor (FGF-2) overexpression is a risk factor for esophageal cancer recurrence and reduced survival, which is ameliorated by coexpression of the FGF-2 antisense gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Fibroblast growth factor receptor 2-positive fibroblasts provide a suitable microenvironment for tumor development and progression in esophageal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Increased midkine gene expression in human gastrointestinal cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Frequent expression of midkine gene in esophageal cancer suggests a potential usage of its promoter for suicide gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Expression of midkine and its clinical significance in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Role of genetic polymorphisms in tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Vascular endothelial growth factor polymorphisms and esophageal cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Genetic variations in angiogenesis pathway genes predict tumor recurrence in localized adenocarcinoma of the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Serum midkine levels are increased in patients with various types of carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Detection of serum p53 antibodies in mucosal esophageal cancer and negative conversion after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Prognostic significance of serum p53 antibody in patients with esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Autoantibodies against MMP-7 as a novel diagnostic biomarker in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Presence of serum tripartite motif-containing 21 antibodies in patients with esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Identification of Makorin 1 as a novel SEREX antigen of esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Detection of anti-CUEC-23 antibodies in serum of patients with esophageal squamous cell carcinoma: a possible new serum marker for esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Identification of a novel SEREX antigen family, ECSA, in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Presence of serum p53 antibodies is associated with decreased in vitro chemosensitivity in patients with esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Changes of serum p53 antibodies and clinical significance of radiotherapy for esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X

Perioperative Changes of Serum p53 Antibody Titer is a Predictor for Survival in Patients with Esophageal Squamous Cell Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10388-012-0332-X